PrairieView Partners’s DexCom DXCM Stock Holding History

PrairieView Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-800	Closed	-$74K	–	375
2023 Q3	$74K	Hold	800	–	–	0.01%	150
2023 Q2	$102K	Buy	+800	New	+$96.8K	0.01%	150

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PrairieView Partners's DXCM Position: Q4 2023 in Review

PrairieView Partners sold out of DexCom (DXCM) in Q4 2023, closing a stake of 800 shares — an estimated $74K sold.

PrairieView Partners first reported a position in DXCM in Q2 2023 and held it in 2 quarters. The position peaked at $102K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

PrairieView Partners reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
PrairieView Partners sold 800 DexCom shares in Q4 2023, an estimated $74K.
PrairieView Partners first reported a position in DexCom in Q2 2023 and held it in 2 quarters.
PrairieView Partners's DexCom position peaked at $102K in Q2 2023.
974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on PrairieView Partners's 13F filing for Q4 2023, filed 26 Jan 2024.